Related Experiment Video
Updated: May 2, 2026
In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
Published on: December 9, 2016
[Effect of sodium fluoroacetate on Ehrlich solid tumor and autochthonous sarcoma growth in mice]
Abstract:
Due to biochemical characteristics of toxic action of fluoroacetate on energetics and metabolism of cells, including tumor cells, it was interesting to testify sodium fluoroacetate (SFA) for its antitumor activity in vivo. We have estimated that SFA significantly inhibits growth of Ehrlich tumor carcinoma. In experiments with autochthonous induced by benzo[a]pyrene subcutaneous tumors, SFA was not active in monotherapy regime, though potentiated antitumor effect of cyclophosphamide, significantly increasing the relative number of mice with stabilized or decreased tumor volume as well as the duration of this effect. The data obtained render basis for additional studies of mechanism of antitumor effect of SFA.
Insights
Sodium fluoroacetate (SFA) shows promise as an antitumor agent, significantly inhibiting Ehrlich tumor growth. SFA also enhanced cyclophosphamide
Area of Science:
- Biochemistry
- Cell Metabolism
- Cancer Research
Context:
- Investigating the biochemical mechanisms of fluoroacetate toxicity.
- Exploring the potential of sodium fluoroacetate (SFA) as an anticancer therapeutic.
- Evaluating SFA's efficacy against various tumor models in vivo.
Purpose:
- To assess the antitumor activity of sodium fluoroacetate (SFA) in vivo.
- To determine SFA's effect on Ehrlich tumor carcinoma growth.
- To investigate SFA's potential in combination therapy for chemically induced tumors.
Summary:
- Sodium fluoroacetate (SFA) significantly inhibited Ehrlich tumor carcinoma growth in vivo.
- SFA demonstrated monotherapy inefficacy against benzo[a]pyrene-induced tumors but potentiated cyclophosphamide's effect.
- Combination therapy with SFA and cyclophosphamide increased tumor volume stabilization and duration of effect.
Impact:
- Provides a basis for further research into SFA's antitumor mechanisms.
- Suggests SFA as a potential adjuvant in cancer chemotherapy.
- Highlights the differential activity of SFA based on tumor type and treatment regimen.
